Skip to main content
logo
Cannara Biotech Inc. (LOVFF)
OTCMKTS · Delayed Price · Currency is USD
1.330
-0.005 (-0.37%)
At close: Jan 6, 2026

Cannara Biotech Revenue

In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.20M CAD with 31.14% growth. Cannara Biotech had revenue of 28.52M in the quarter ending August 31, 2025, with 23.02% growth.

Revenue
107.20M CAD
Revenue Growth
+31.14%
P/S Ratio
1.61
Revenue / Employee
237.17K CAD
Employees
452
Market Cap
125.74M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 2025107.20M25.45M31.14%
Aug 31, 202481.75M24.49M42.77%
Aug 31, 202357.26M21.42M59.76%
Aug 31, 202235.84M18.82M110.58%
Aug 31, 202117.02M14.47M567.24%
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Glass House Brands196.17M
Global Cord Blood196.10M
Elite Pharmaceuticals122.89M
Silence Therapeutics25.83M
OpGen9.00M
Northwest Biotherapeutics937.00K
Revenue Rankings

Cannara Biotech News

More News